Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Assessment of compliance with hormonal therapy in early breast cancer patients with positive hormone receptor phenotype: A single institution study.

Breast (Edinburgh, Scotland) - 1 Apr 2022

Elsamany Shereef Ahmed, Alghanmi Hossam, Albaradei Abdelrahman, Abdelhamid Rasha, Madi Eman, Ramzan Amira

Abstract excerpt

BACKGROUND: Adherence to long-term adjuvant hormonal therapy in hormonal receptors (HR)-positive breast cancer is really challenging and can affect the survival outcome. The present study aims to assess rate of compliance with hormonal therapy and possible predictive factors in a single institute in Saudi Arabia. PATIENTS &METHODS: We recruited patients with HR-positive breast cancer who presented to oncology...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Chemotherapy, Adjuvant

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hormones

Share to Patient Compliance

Share to Phenotype

Source

Open in PubMed Open full text

Identifiers

PMID: 35131645
DOI: 10.1016/j.breast.2022.01.017
PMCID: PMC9073292

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Assessment of compliance with hormonal therapy in early breast cancer patients with positive hormone receptor phenotype: A single institution study.PMID 35131645Read ↗

The lived experience of breast cancer patients on adjuvant endocrine therapy: Side effects and coping strategies during the first year of medication initiationSemantic proximity Read ↗

Preventing metastatic recurrence in low-risk ER/PR+ breast cancer patients – a retrospective clinical study exploring the evolving challenge of persistence with adjuvant endocrine therapySemantic proximity Read ↗

Racial and ethnic differences in adjuvant hormonal therapy use.Semantic proximity Read ↗

Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey.Semantic proximity Read ↗

The 21-gene recurrence score assay improved MDT compliance in HR+/ HER2- breast cancer patients：An analysis of 2323 patientsSemantic proximity Read ↗

The relationship between post-diagnostic statin usage and breast cancer prognosis varies by hormone receptor phenotype: a systemic review and meta-analysis.Semantic proximity Read ↗

Exogenous reproductive hormone use in breast cancer survivors and previvors.Semantic proximity Read ↗

Development and Validation of a Questionnaire on Knowledge, Attitudes, and Practices of Breast Specialist Nurses Regarding Fertility Preservation in Breast Cancer Patients of Childbearing AgeSemantic proximity Read ↗

Adherence to endocrine therapy in early breast cancer in relation to Cytochrome P450 2D6 genotype: a comparison between pharmacy dispensation data and medical records.Semantic proximity Read ↗

Pharmacogenetics of hormone replacement therapy for climacteric symptoms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.